Octavia M. Peck‐Palmer
University of Pittsburgh Medical Center(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Sepsis Diagnosis and Treatment, Cell death mechanisms and regulation, Immune Response and Inflammation
Most-Cited Works
- → Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection(2018)422 cited
- → Monocyte Distribution Width: A Novel Indicator of Sepsis-2 and Sepsis-3 in High-Risk Emergency Department Patients*(2019)167 cited
- → Deletion of MyD88 markedly attenuates sepsis-induced T and B lymphocyte apoptosis but worsens survival(2008)74 cited
- → Quality Control Practices for Chemistry and Immunochemistry in a Cohort of 21 Large Academic Medical Centers(2018)69 cited
- → BIM siRNA DECREASES LYMPHOCYTE APOPTOSIS AND IMPROVES SURVIVAL IN SEPSIS(2008)62 cited
- → Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge(2022)52 cited
- → MODULATION OF THE BCL-2 FAMILY BLOCKS SEPSIS-INDUCED DEPLETION OF DENDRITIC CELLS AND MACROPHAGES(2009)51 cited
- → Variable Performance in 6 Commercial SARS-CoV-2 Antibody Assays May Affect Convalescent Plasma and Seroprevalence Screening(2020)30 cited
- → The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial(2022)26 cited
- → The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization(2021)25 cited